Sue Rataj - Agilent Technologies Independent Director

A Stock  USD 147.37  2.96  2.05%   

Director

Ms. Sue H. Rataj is Independent Director of Agilent Technologies, Inc since 2015.
Age 63
Tenure 9 years
Address 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051
Phone800 227 9770
Webhttps://www.agilent.com
Rataj was Chief Executive, Petrochemicals for BP, a global energy company, until she retired in April 2011. In this role, she held responsibility for all of BP’s global petrochemical operations. Prior thereto, Ms. Rataj held a variety of senior management positions with BP, most recently serving as Group Vice President, Health, Safety, Operations and Technology for the Refining and Marketing Segment.

Agilent Technologies Management Efficiency

The company has return on total asset of 0.0785 % which means that for every 100 dollars spent on assets, it generated a profit of $0.0785. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2095 %, implying that it made 0.2095 on every $100 invested by shareholders. Agilent Technologies' management efficiency ratios could be used to measure how well Agilent Technologies manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 0.14, whereas Return On Assets are forecasted to decline to 0.05. At present, Agilent Technologies' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 283.8 M, whereas Total Assets are forecasted to decline to about 9.3 B.
The company has accumulated 2.73 B in total debt with debt to equity ratio (D/E) of 0.52, which looks OK as compared to the sector. Agilent Technologies has a current ratio of 1.99, which is considered satisfactory as compared to similar companies. Debt can assist Agilent Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Agilent Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Agilent Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Agilent to invest in growth at high rates of return. When we think about Agilent Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Lorence KimSeres Therapeutics
43
Charles McDermottEquillium
45
Vickie DriverMediwound
N/A
Stephen WillsMediwound
58
Aharon YaariMediwound
63
Anders Forseback23Andme Holding Co
N/A
Donald KufeMadrigal Pharmaceuticals
69
Willard DereSeres Therapeutics
64
Bruce KovnerMadrigal Pharmaceuticals
69
Kenneth BateMadrigal Pharmaceuticals
67
Stephen ConnellyEquillium
42
Salvatore Falco23Andme Holding Co
46
Werner CautreelsSeres Therapeutics
N/A
Bala ManianEquillium
72
Paul FriedmanMadrigal Pharmaceuticals
75
Staffan Gavel23Andme Holding Co
67
David BerrySeres Therapeutics
37
John FisherEquillium
60
Kurt GravesSeres Therapeutics
50
Robert WilsonMadrigal Pharmaceuticals
75
Helena Herlogsson23Andme Holding Co
N/A
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California. Agilent Technologies operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 18000 people. Agilent Technologies (A) is traded on New York Stock Exchange in USA. It is located in 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 and employs 17,700 people. Agilent Technologies is listed under Life Sciences Tools & Services category by Fama And French industry classification.

Management Performance

Agilent Technologies Leadership Team

Elected by the shareholders, the Agilent Technologies' board of directors comprises two types of representatives: Agilent Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Agilent. The board's role is to monitor Agilent Technologies' management team and ensure that shareholders' interests are well served. Agilent Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Agilent Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Philip Binns, Senior Group
Padraig McDonnell, Senior Vice President and Presidentident - Agilent CrossLab Group
Daniel Podolsky, Independent Director
Hans Bishop, Independent Director
George Scangos, Independent Director
Sue Rataj, Independent Director
Jacob Thaysen, Senior Vice President, Agilent, President - Life Sciences and Applied Markets Group
Darlene Solomon, CTO VP
Samraat Raha, Senior Vice President, Agilent, President - Diagnostics and Genomics Group
Mark Doak, Senior Vice President, President - Agilent CrossLab Group
Paul Clark, Independent Director
Mala Anand, Independent Director
Jenipher Dalton, Chief VP
Robert McMahon, Chief Financial Officer, Senior Vice President
Ankur Dhingra, Investor Relations
John Kohl, Senior Officer
Mikael Dolsten, Independent Director
Allison Ballmer, Vice President - Strategy and Corporate Development
Hajime Tada, Interim General Counsel
James Cullen, Independent Non-Executive Chairman of the Board
Michael McMullen, CEO and President Director and Member of Executive Committee
Patrick Kaltenbach, Sr. VP and President of Life Sciences and Applied Markets Group (LSAG) Bus. Unit
Rodney Gonsalves, Chief Accounting Officer, Vice President, Corporate Controllership
Henrik AncherJensen, Senior Vice President, Agilent and President - Order Fulfillment
Dow Wilson, Independent Director
Diana Chiu, Interim VP
Heidi Kunz, Independent Director
Otis Brawley, Independent Director
Dominique Grau, Senior Vice President of Human Resources and Global Communications
Susan Rataj, Independent Director
Heidi Fields, Independent Director
Michael Tang, Senior Vice President General Counsel, Secretary
Alicia Rodriguez, Vice President - Investor Relations
Tadataka Yamada, Independent Director
Didier Hirsch, CFO and Sr. VP
Katharine Knobil, Chief Medical Officer.
Boon Koh, Non-Executive Independent Chairman of the Board
Robert Herbold, Independent Director
Yvonne Mackie, MD Europe

Agilent Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Agilent Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Agilent Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agilent Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agilent Technologies will appreciate offsetting losses from the drop in the long position's value.

Moving together with Agilent Stock

  0.68MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
  0.62EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against Agilent Stock

  0.76KA Kineta Inc Report 29th of March 2024 PairCorr
  0.72MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.67MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.52MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.41VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Agilent Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Agilent Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Agilent Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Agilent Technologies to buy it.
The correlation of Agilent Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agilent Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agilent Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Agilent Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Agilent Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agilent Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agilent Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agilent Technologies Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agilent Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Agilent Stock refer to our How to Trade Agilent Stock guide.
Note that the Agilent Technologies information on this page should be used as a complementary analysis to other Agilent Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Agilent Stock analysis

When running Agilent Technologies' price analysis, check to measure Agilent Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agilent Technologies is operating at the current time. Most of Agilent Technologies' value examination focuses on studying past and present price action to predict the probability of Agilent Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Agilent Technologies' price. Additionally, you may evaluate how the addition of Agilent Technologies to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Is Agilent Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilent Technologies. If investors know Agilent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilent Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.01)
Dividend Share
0.911
Earnings Share
4.19
Revenue Per Share
22.967
Quarterly Revenue Growth
(0.06)
The market value of Agilent Technologies is measured differently than its book value, which is the value of Agilent that is recorded on the company's balance sheet. Investors also form their own opinion of Agilent Technologies' value that differs from its market value or its book value, called intrinsic value, which is Agilent Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilent Technologies' market value can be influenced by many factors that don't directly affect Agilent Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilent Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilent Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilent Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.